BiotechTube
Home/Gb Sciences/John Poss
JP

John Poss

Chief Executive Officer (CEO)

Gb Sciences

Therapeutic Areas

NeurologyInflammation/ImmunologyCardiology

Gb Sciences Pipeline

DrugIndicationPhase
Cannabinoid-based TherapyParkinson's DiseasePreclinical
Therapy for Cytokine ReleaseCOVID-Related HyperinflammationPreclinical
TRPV1-targeting TherapyHeart Failure / Cardiac HypertrophyPreclinical

Leadership Team at Gb Sciences

DA
Dr. Andrea Small-Howard
Chief Science Officer (CSO)
View full Gb Sciences profile